Literature DB >> 28682740

"Like Holding an Umbrella Before It Rains": Acceptability of Future Rectal Microbicides Among Men Who Have Sex With Men in India-A Modified Technology Acceptance Model.

Venkatesan Chakrapani1,2,3, Peter A Newman4, Murali Shunmugam1, Shruta Mengle2, Ruban Nelson1, Clara Rubincam4, Pushpesh Kumar5.   

Abstract

Topical rectal microbicides (RMs) are a new prevention technology in development that aims to reduce the risk of HIV acquisition from anal sex. We examined RM acceptability among men who have sex with men (MSM) in India. We conducted a qualitative exploratory study guided by a modified Technology Acceptance Model, with 10 focus groups ( n = 61) of MSM and 10 key informant interviews. Data were explored using framework analysis. RM acceptability was influenced by technological contexts: perceived usefulness of RMs, perceived ease of use of RM and applicator, and habits around condom and lubricant use; individual and interpersonal contexts: perceived relevance and preferences for product formulation and dosing frequency; and MSM community/social contexts: perceived social approval, RM-related stigma, social support. Implementation of RMs for MSM in India may be supported by multi-level interventions that engage community-based organizations in destigmatizing and distributing RMs, ideally gel-based products that enable on-demand use before sex.

Entities:  

Keywords:  HIV prevention; HIV/AIDS; India; acceptability; focus groups; framework analysis; interviews; male sex workers; men who have sex with men; qualitative; rectal microbicide

Mesh:

Substances:

Year:  2017        PMID: 28682740     DOI: 10.1177/1049732317697947

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  5 in total

1.  Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment.

Authors:  Venkatesan Chakrapani; Peter A Newman; Michael Cameron; Murali Shunmugam; Surachet Roungprakhon; Shruta Rawat; Dicky Baruah; Ruban Nelson; Suchon Tepjan; Riccardo Scarpa
Journal:  AIDS Behav       Date:  2021-04-05

2.  Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use.

Authors:  Kate M Guthrie; Rochelle K Rosen; Melissa Guillen; Jaime J Ramirez; Sara E Vargas; Joseph L Fava; Anthony S Ham; David F Katz; Susan Cu-Uvin; Sheila Tumilty; Kelley A Smith; Karen W Buckheit; Robert W Buckheit
Journal:  AIDS Res Hum Retroviruses       Date:  2021-10-18       Impact factor: 1.723

3.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

4.  Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.

Authors:  Millicent Atujuna; Peter A Newman; Melissa Wallace; Megan Eluhu; Clara Rubincam; Ben Brown; Linda-Gail Bekker
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

5.  User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.

Authors:  Kate M Guthrie; Rochelle K Rosen; Sara E Vargas; Melissa L Getz; Lauren Dawson; Melissa Guillen; Jaime J Ramirez; Marc M Baum; Kathleen L Vincent
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.